Vancive and Aspen Medical partner to distribute absorbent wound dressing products in the UK, Ireland

Oct 25 2014

Vancive Medical Technologies™ and Aspen Medical Europe Ltd. (“Aspen Medical”) today announced an agreement for the exclusive distribution of the Vancive BeneHold™ Absorbent Wound Dressing portfolio in the United Kingdom and Ireland.

The BeneHold range comprises three product lines, each of which offers specific performance and value to the clinician and patient. The three product lines, which are available on the Drug Tariff as of October 1, 2014 are:

• Thin Absorbent Wound Dressing featuring TASA™ (Thin Absorbent Skin Adhesive™);
• Bordered Hydrocolloid Dressing with Odor Control (available in two advanced formulations); and the
• Standard Hydrocolloid Dressing.

“We are pleased to have Aspen Medical as our partner, as we share a similar mission bringing innovative products to improve patient outcomes and patient experience with healthcare economics in mind,” said Howard Kelly, president and general manager of Vancive. “By adding technologies like TASA™ and advanced hydrocolloids that complement Aspen’s portfolio of advanced wound care products, we provide a comprehensive solution to meet the needs of the practitioner.”

The Bordered Hydrocolloid Dressing with Odor Control is formulated with non-cytotoxic cyclodextrins that capture odor molecules to help increase patient confidence. The dressings have a superior fluid handling capacity compared with existing products at equivalent thickness.

The Thin Absorbent Dressings are based on Vancive’s proprietary TASA™ (Thin Absorbent Skin Adhesive™) technology. At only 0.12mm, TASA™ dressings are less than half the thickness of other “thin” hydrocolloids. This translates to superior conformability, exceptional transparency and less opportunity for the dressing’s edge to lift off of the skin.

In early evaluations of the BeneHold™ Absorbent Wound Dressings, clinicians found that longer wear times can be achieved, especially on hard-to-dress or moisture-complicated areas. Nurses found them easy to work with, and patients found them to be comfortable to wear and atraumatic to remove. Because of its thinness, transparency, and the unique way it manages moisture, TASA™ was particularly well received.

“The Aspen Medical team looks forward to working with Vancive and its Benehold™ product range to provide wound care practitioners solutions that will help them meet their clinical challenges,” said Chris Hill, Sales and Marketing Director, Aspen Medical Europe Limited. “This technology, along with Vancive traditional and enhanced Hydrocolloids, is a good fit within our portfolio of products.  Hydrocolloid technology has an important and ongoing role to play in wound management.”

The products will be launched jointly by Vancive and Aspen Medical at the Wounds UK conference in Harrogate on 10-12 November.